Mylabris phalerlata induces apoptosis by caspase activation following cytochrome c release and Bid cleavage

Life Sciences

Volumn 73, Issue 17, 2003, Pages 2249-2262

  Huh, Jeong Eun ^a   Kang, Kyung Sun ^b   Ahn, Kyoo Seok ^a   Kim, Dong Hee ^c   Saiki, Ikuo ^d   Kim, Sung Hoon ^a  

^a Kyung Hee University   (South Korea)

^b Seoul National University   (South Korea)

^c Department of Pathology Daejeon University College of Oriental Medicine   (South Korea)

^d UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Annexin V; Apoptosis; BFMP (BuOH fraction of Mylabris phalerata); Bid; Caspase; Cytochrome c; Mylabris phalerata; PARP; PBML

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DNA FRAGMENT; LIPOCORTIN 5; MYLABRIS PHALERLATA EXTRACT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; UNCLASSIFIED DRUG;

ANOIKIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPATHOGENIC EFFECT; CYTOSOL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IC 50; INSECT; MITOCHONDRION; MONONUCLEAR CELL; MYLABRIS PHALERLATA; PROTEIN DEGRADATION;

INSECTA; MYLABRIS;

EID: 0042090398     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00568-X     Document Type: Article

References (40)

1. Araya R., Uehara T., Nomura Y. Hypoxia induces apoptosis in human neuro blastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Letters. 439:1998;168-172.
2. Arens M.J., Morris R.G., Wyllie A.H. Apoptosis. The role of the endonuclease. American Journal of Pathology. 136:1990;593-608.
3. Ata N., Oku T., Hattori M., Fujii H., Nakajima M., Saiki I. Inhibition by galloyl glucose (GG6 -10) of tumor invasion through extracellular matrix and gelatinase-mediated degradation of type IV collagens by metastatic tumor cells. Oncology Research. 8:1996;503-511.
4. Bossy-Wetzel E., Newmeter D.D., Green D.R. Mitochondria cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. The EMBO Journal. 17:1998;37-49.
5. Boulares A.H., Zoltoski A.J., Yakovlev A., Xu M., Suulson M.E. Roles of DNA fragmentation factor and poly(ADP)polymerase in an amplification phase of tumor necrosis factor induced apoptosis. The Journal of Biological Chemistry. 276:2001;38185-38192.
6. Chang H.Y., Yang X. Proteases for suicide: functions and regulation of caspases. Microbiology Molecular Biology Review. 64:2000;621-646.
7. Chauhan D., Pandey P., Ogata A., Teoh G., Krett N., Halgren R., Rosen S., Kufe D., Kharbanda S., Anderson K. Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells. The Journal of Biological Chemistry. 272:1997;29995-29997.
8. Chen R.T., Hua Z., Yang J.L., Han J.X., Zhang S.Y., Lu F.L., Xu B. Studies on anti tumor actions of cantharidin. National Medicinal Journal of China. 57:1977;475-478.
9. Cohen G.M., Sun X.M., Snowden R.T., Dinsdale D., Skilleter D.N. Key molecular features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochemical Journal. 286:1992;331-334.
10. Denecker G., Vercammen D., Declercq W., Vendenabeele P. Apoptotic and necrotic cell death induced by death domain receptors. Cellular Molecular Life Science. 58:2001;356-370.
11. Eldridge R., Casida J.E. Cantharidin effects on protein phosphatase and the phosphorylation state of phosphoproteins in mice. Toxicological Applied Pharmacology. 130:1995;95-100.
12. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
13. Gavricli F., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. The Journal of Cell Biology. 119:1992;493-501.
14. Gupta S.K., Sargent J.R., Weber W.P. Fractionation of moderate molecular weight polysiloxanes by centrifugal TLC. Analytical Chemistry. 73:2001;3781-3783.
15. 2/M apoptosis id dependent on wild type p53 gene. Biochemical and Biophysical Research Communications. 276:2000;278-285.
16. Honkanen R.E. Cantharidin, another natural toxin that inhibits the activity of serine/ threonine protein phosphatases types 1 and 2A. FEBS Letters. 330:1993;283-286.
17. Katja C.Z., Christine B., Douglas R.G. The machinery of programmed cell death. Pharmacology and Therapeutics. 92:2001;57-90.
18. Kingston D.G., Chaudhary A.G., Chordia M.D., Gharpure M., Gunatilaka A.A., Higgs P.I., Rimoldi J.M., Samala L., Jagtap P.G., Giannakakou P., Jiang Y.Q., Lin C.M., Hamel E., Long B.H., Fairchild C.R., Johnston K.A. Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol). Journal of Medicinal Chemistry. 41:1998;3715-3726.
19. Kroemer G., Petit P., Zamzami N., Vayssiere J.L., Mignotte B. The biochemistry of programmed cell death. FASEB Journal. 9:1995;1277-1287.
20. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of Bid by caspase 8 mediates the motochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
21. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemuri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apa-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
22. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
23. Li Y.M., Casida J.E. Cantharidin binding protein, identification as protein phosphatase 2A. Proceeding of the National Academy of Science of the United State of America. 89:1992;11867-11870.
24. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl 2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
25. Majno G., Joris I. Apoptosis and necrosis: an overview of cell death. American Journal of Pathology. 46:1995;3-15.
26. Martin S.J., Finucane D.M., Amarante M.G.P., O'Brian G.A., Green D.R. Phosphatidyl-serine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. The Journal of Biological Chemistry. 271:1996;28753-28756.
27. Nishizaki K., Yoshino T., Orita Y., Nomiya S., Masuda Y. TUNEL staining of inner ear structures may reflect autolysis, not apoptosis. Hearing Research. 871:1999;160-164.
28. Qu M., Xu H., Li Y., Luo H. An illustrated guide to antineoplastic Chinese herbal medicine. The Commercial. 1990;144-145.
29. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
30. Tagwireyi D., Ball D.E., Loga P.J., Moyo S. Cantharidin poisoning due to "bister beetle" ingestion. Toxicon. 38:2000;1865-1869.
31. Tang D., Lahti J.M., Kidd V.J. Caspase-8 activation and Bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during Staurosporine-mediated apoptosis. The Journal of Biological Chemistry. 275:2000;9303-9307.
32. Thompson C.B. Apoptosis in the pathogenesis and treatment of diseases. Science. 267:1995;615-631.
33. Thornberry N.A. Caspases: key mediators of apoptosis. Chemistry and Biology. 5:1998;R97-R103.
34. Vermes I., Haanen C., Stefens Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flowcytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. Journal of Immunological Methods. 184:1995;39-51.
35. Viswanath V., Wu Y., Boonplueang R., Chen S., Stevenson F.F., Yantiri F., Yang L., Beal F., Anderson J.K. Caspase-9 activation results in downstream caspase-8 activation and Bid cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-induced Parkinson's disease. Journal of Neuroscience. 21:2001;9519-9528.
36. Wall M.E. Camptothecin and taxol: discovery to clinic. Medicinal Research Reviews. 18:1998;299-314.
37. Wang C.C., Wu C.H., Hsieh K.J., Yen K.Y., Yang L.L. Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells. Toxicology. 147:2000;77-87.
38. Wang G.S. Medical uses of mylabris in ancient China and recent studies. Journal of Ethnopharmacology. 26:1989;147-162.
39. Yang E.B., Tang W.Y., Zhang K., Cheng L.Y., Mack P.O.P. Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival. Cancer Letters. 117:1997;93-98.
40. Zhang J.H., Ming X.U. DNA fragmentation in apoptosis. Cell Research. 10:2000;205-211.